Trametinib and Dabrafenib in histiocytic sarcoma transdifferentiated from chronic lymphocytic leukemia with a K-RAS and a unique BRAF mutation.
Georgios RassidakisOlga StrombergIoanna XagorarisKenbugul JattaKristina SonneviPublished in: Annals of hematology (2020)